The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent Mechanism
Open accessAbstract
Insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) is known to block IGF action and inhibit cell growth. IGFBP-3 is thought to act by sequestering free IGFs or, possibly, act via a novel IGF-independent mechanism. Supporting its role as a primary growth inhibitor, IGFBP-3 production has been shown to be increased by cell growth-inhibitory agents, such as transforming growth factor-beta (TGF-beta), and the tumor suppressor gene p53. In this paper, we demonstrate, for the first time, a novel function of IGFBP-3 as an apoptosis-inducing agent and show that this action is mediated through an IGF.IGF receptor-independent pathway. In the p53 negative prostate cancer cell line, PC-3, the addition of recombinant IGFBP-3 resulted in a dose-dependent induction of apoptosis. 125I-IGFBP-3 bound with high affinity to specific proteins in PC-3 cell lysates and plasma membrane preparations. These membrane-associated molecules may serve as receptors that mediate the direct effect of IGFBP-3 on apoptosis. In addition, in an IGF receptor-negative mouse fibroblast cell line, treatment with recombinant IGFBP-3 as well as transfection of the IGFBP-3 gene induced apoptosis, suggesting that neither IGFs nor IGF receptors are required for this action. Furthermore, treatment with TGF-beta1, a known apoptosis-inducing agent, resulted in the induction of IGFBP-3 expression 6-12 h before the onset of apoptosis. This effect of TGF-beta1 was prevented by co-treatment with IGFBP-3-neutralizing antibodies or IGFBP-3-specific antisense thiolated oligonucleotides. These findings suggest that IGFBP-3 induces apoptosis through a novel pathway independent of either p53 or the IGF.IGF receptor-mediated cell survival pathway and that IGFBP-3 mediates TGF-beta1 induced apoptosis in PC-3 cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vermes, I., Haanen, C., Steffens-Nakken, H., & Reutellingsperger, C. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00072-i · Cited by 5,410
Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*
JONES, J. I., & CLEMMONS, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,710
Koopman, G., Reutelingsperger, C., Kuijten, G., Keehnen, R., Pals, S., & van Oers, M. (1994) · Blood · doi:10.1182/blood.v84.5.1415.1415 · Cited by 2,681
Induction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869
Fas- and Tumor Necrosis Factor-induced Apoptosis Is Inhibited by the Poxvirus crmA Gene Product
Tewari, M., & Dixit, V. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3255 · Cited by 596
Sell, C., Rubini, M., Rubin, R., Liu, J. P., Efstratiadis, A., & Baserga, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11217 · Cited by 553
Selvakumaran, M., Lin, H. K., Miyashita, T., Wang, H., Krajewski, S., Reed, J., Hoffman‐Liebermann, B., & Liebermann, D. A. (1994) · PubMed · Cited by 478
Oh, Y., Müller, H. L., Lamson, G., & Rosenfeld, R. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82426-7 · Cited by 472
Homburg, C., de Haas, M., von dem Borne, A., Verhoeven, A., Reutelingsperger, C., & Roos, D. (1995) · Blood · doi:10.1182/blood.v85.2.532.532 · Cited by 431
Werner, H., Karnieli, E., Rauscher, F. J., & LeRoith, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8318 · Cited by 370
Valentinis, B. (1995) · Molecular Endocrinology · doi:10.1210/me.9.3.361 · Cited by 327
Self-citationInsulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis.
Sell, C., Baserga, R., & Rubin, R. (1995) · PubMed · Cited by 287
A Mutant p53 That Discriminates between p53-Responsive Genes Cannot Induce Apoptosis
Friedlander, P., Haupt, Y., Prives, C., & Oren, M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4961 · Cited by 278
Differential Activation of Target Cellular Promoters by p53 Mutants with Impaired Apoptotic Function
Ludwig, R. L., Bates, S., & Vousden, K. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4952 · Cited by 275
Cohen, P., Peehl, D. M., Graves, H. C. B., & Rosenfeld, R. G. (1994) · Journal of Endocrinology · doi:10.1677/joe.0.1420407 · Cited by 268
Self-citationGucev, Z. S., Oh, Y., Kelley, K. M., & Rosenfeld, R. G. (1996) · PubMed · Cited by 253
Oh, Y., Müller, H. L., Ng, L., & Rosenfeld, R. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13589 · Cited by 237
Conover, C. A. (1992) · Endocrinology · doi:10.1210/en.130.6.3191 · Cited by 230
Huynh, H., Yang, X., & Pollak, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.1016 · Cited by 219
D4-GDI, a Substrate of CPP32, Is Proteolyzed during Fas-induced Apoptosis
Na, S., Chuang, T.-H., Cunningham, A., Turi, T. G., Hanke, J. H., Bokoch, G. M., & Danley, D. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11209 · Cited by 211
Planchon, S. M., Wuerzberger‐Davis, S. M., Frydman, B., Witiak, D. T., Hutson, P. R., Church, D. R., Wilding, G., & Boothman, D. A. (1995) · PubMed · Cited by 202
Insulin-like Growth Factor-II Is an Autocrine Survival Factor for Differentiating Myoblasts
Stewart, C. E. H., & Rotwein, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11330 · Cited by 198
Troy, C. M., Stefanis, L., Prochiantz, A., Greene, L. A., & Shelanski, M. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5635 · Cited by 190
Tewari, M., Beidler, D. R., & Dixit, V. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18738 · Cited by 178
Angelloz-Nicoud, P. (1995) · Endocrinology · doi:10.1210/en.136.12.5485 · Cited by 167
Cohen, P. (1993) · Molecular Endocrinology · doi:10.1210/me.7.3.380 · Cited by 165
Self-citationGiudice, L. C., Dsupin, B. A., Jin, I. H., Vu, T. H., & Hoffman, A. R. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.5.8496300 · Cited by 139
c‐Myc induces cellular susceptibility to the cytotoxic action of TNF‐alpha.
Klefström, J. T., Västrik, I., SAKSELA, E., Valle, J., Eilers, M., & Alitalo, K. K. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06879.x · Cited by 138
Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-XL
Benito, A., Silva, M., Grillot, D., Núñez, G., & Fernandez-Luna, J. (1996) · Blood · doi:10.1182/blood.v87.9.3837.bloodjournal8793837 · Cited by 128
Tsukada, T., Eguchi, K., Migita, K., Kawabe, Y., Kawakami, A., Matsuoka, N., Takashima, H., Mizokami, A., & Nagataki, S. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1766 · Cited by 104
Goldstein, S., Moerman, E. J., Jones, R. A., & Baxter, R. C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9680 · Cited by 104
Adamo, M. L., Shao, Z. M., Lanau, F., Chen, J. C., Clemmons, D. R., Roberts, C. T., LeRoith, D., & Fontana, J. A. (1992) · Endocrinology · doi:10.1210/en.131.4.1858 · Cited by 97
Clinical aspects of insulin-like growth factor binding proteins.
Cohen, P., Fielder, P. J., Hasegawa, Y., et al. (1991) · PubMed · Cited by 97
Self-citationYateman, M., Dc, C., Hughes, S. C. C., Frost, V. J., Wass, J. A. H., & Holly, J. M. P. (1993) · Journal of Endocrinology · doi:10.1677/joe.0.1370151 · Cited by 86
Insulin‐like growth factor binding proteins and their regulation
Rosenfeld, R. G., Pham, H. M., Cohen, P., Fielder, P. J., Gargosky, S. E., Muller, H. L., Nonoshita, L., & Oh, Y. (1994) · Acta Paediatrica · doi:10.1111/j.1651-2227.1994.tb13315.x · Cited by 55
Self-citationDeckers, C. L. P., Lyons, A. B., Samuel, K., Sanderson, A., & MADDY, A. H. (1993) · Experimental Cell Research · doi:10.1006/excr.1993.1257 · Cited by 43
Rorke, E. A., & Jacobberger, J. W. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1008 · Cited by 39
Estrov, Z., Black, R., Sleath, P. R., Harris, D., Van, Q., LaPushin, R., Estey, E., & Talpaz, M. (1995) · Blood · doi:10.1182/blood.v86.12.4594.bloodjournal86124594 · Cited by 39
Moerman, E. J., Thweatt, R., Moerman-Herzog, A. M., Jones, R. A., & Goldstein, S. (1993) · Experimental Gerontology · doi:10.1016/0531-5565(93)90063-j · Cited by 31
Cited by
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Firth, S. M., & Baxter, R. C. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0033 · Cited by 1,750
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
Yu, H. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1472 · Cited by 1,424
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Colao, A., Ferone, D., Marzullo, P., & Lombardi, G. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0022 · Cited by 1,309
Ma, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H., & Stampfer, M. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.620 · Cited by 1,119
Metadata
- Authors
- Rajah, R., Valentinis, B., & Cohen, P.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-05
- Volume
- 272
- Issue
- 18
- Pages
- 12181-12188
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2077956417
- Cited by
- 722
- References
- 39
- FWCI
- 35.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.